Saroja Pharma Industries India Limited (NSE:SAROJA)
India · Delayed Price · Currency is INR 43.70
-2.30 (-5.00%)
At close: Sep 26, 2025
NSE:SAROJA Revenue
In the fiscal year ending March 31, 2025, Saroja Pharma Industries India had annual revenue of 537.27M INR with 32.11% growth. Saroja Pharma Industries India had revenue of 350.03M in the half year ending March 31, 2025, with 47.98% growth.
Revenue
537.27M
Revenue Growth
+32.11%
P/S Ratio
0.33
Revenue / Employee
n/a
Employees
12
Market Cap
175.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 537.27M | 130.58M | 32.11% |
| Mar 31, 2024 | 406.69M | -95.24M | -18.97% |
| Mar 31, 2023 | 501.93M | -54.39M | -9.78% |
| Mar 31, 2022 | 556.33M | 189.71M | 51.75% |
| Mar 31, 2021 | 366.62M | 195.82M | 114.65% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Bajaj Finance | 387.76B |
| Infosys | 1,672.76B |